A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...

This antiretroviral has shown unprecedented results in HIV prevention, requiring only two injections per year. Its ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...

Low- and middle-income countries will be able to purchase an effective preventative at a reduced price. The arrangements may ...

Year's supply of injectable to cost Rs 3,549, compared to over Rs 17 lakh in US. Powerful alternative to daily oral PrEP, ...

Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...

Gilead has agreed to provide the drug at cost and to share its intellectual property with generic manufacturers who can ...

The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...

The Gates Foundation CEO Mark Suzman on Wednesday warned that child mortality is at risk of rising this year for the first ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...